Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement

This working document might be considered by the European regulatory authorities in a future update of the guideline for the registration of drugs in OA.